China DUV Chipmaking: How Machine Advances Could Reduce Reliance on ASML, Nvidia
THE SO WHAT
A Shanghai state-backed firm moving toward immersion DUV tools capable of advanced-node production is a strategic attempt to de-risk dependence on ASML and, downstream, Nvidia. Anyone with supply chains tied to leading-edge silicon should now treat Chinese domestic lithography as a medium-term factor in pricing, export controls, and capacity planning.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechFTC Sues Hims & Hers for Allegedly Sharing Private Health Info With Meta and Snap
Regulators are drawing a hard line on health data flowing into ad and social ecosystems—alleged sharing with Meta and Snap puts the entire “growth at any data cost” playbook at risk. If you touch PHI or quasi-health signals, lock down tracking pixels and ad integrations this week.
Deep & Emerging TechFinger Sweat Could Be the Huge Health Upgrade Smart Rings Need
Passive sweat sensing turns wearables from step counters into real metabolic monitors. If this moves from lab to product, health and wellness operators should plan for continuous nutrition and insulin data as an input to coaching, insurance design, and chronic care workflows.
Deep & Emerging TechUSMCA Critical 'Competitiveness Platform' to Compete with China, Says John Bozzella
Treat USMCA less as a trade pact and more as an industrial policy chassis for autos and EV supply chains. If you manufacture or source in this corridor, assume tighter coordination on standards and more scrutiny of Chinese components baked into your compliance and procurement work.
Deep & Emerging TechDeepMind won a Nobel for AlphaFold. Then it broke up the team.
Reassigning much of the AlphaFold team after a Nobel shows how quickly frontier labs rotate talent toward the next platform bet. If you’re a downstream user in biotech, don’t anchor your roadmap to any one research group—anchor it to the productization and support commitments around the tools you rely on.